Sionna Therapeutics Inc
SIONHealthcare|Biotechnology|USA
$45.29
+0.29 (+0.65%)
Tangible Book
$6.39
Clinical Trials (2)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07108153 Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta | Cystic Fibrosis (CF) | P2 | Active | 16 | RCT, Double-blind | SION-719, Placebo-to-match SION-719 |
| NCT07035990 Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants. | Cystic Fibrosis (CF) | P1 | Recruiting | 144 | RCT, Double-blind | SION-451, SION-2222, SION-109, Placebo SION-451, Placebo SION-2222, Placebo SION-109 |